Cargando…
Pharmacological Reactivation of the Silenced FMR1 Gene as a Targeted Therapeutic Approach for Fragile X Syndrome
More than ~200 CGG repeats in the 5′ untranslated region of the FMR1 gene results in transcriptional silencing and the absence of the FMR1 encoded protein, FMRP. FMRP is an RNA-binding protein that regulates the transport and translation of a variety of brain mRNAs in an activity-dependent manner. T...
Autores principales: | Kumari, Daman, Gazy, Inbal, Usdin, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406686/ https://www.ncbi.nlm.nih.gov/pubmed/30759772 http://dx.doi.org/10.3390/brainsci9020039 |
Ejemplares similares
-
Small Molecules Targeting H3K9 Methylation Prevent Silencing of Reactivated FMR1 Alleles in Fragile X Syndrome Patient Derived Cells
por: Kumari, Daman, et al.
Publicado: (2020) -
Repeat-mediated epigenetic dysregulation of the FMR1 gene in the fragile X-related disorders
por: Usdin, Karen, et al.
Publicado: (2015) -
CGG-repeat dynamics and FMR1 gene silencing in fragile X syndrome stem cells and stem cell-derived neurons
por: Zhou, Yifan, et al.
Publicado: (2016) -
Towards Mechanism-Based Treatments for Fragile X Syndrome
por: Kumari, Daman, et al.
Publicado: (2019) -
CGG Repeat Expansion, and Elevated Fmr1 Transcription and Mitochondrial Copy Number in a New Fragile X PM Mouse Embryonic Stem Cell Model
por: Gazy, Inbal, et al.
Publicado: (2020)